| Financial Year |
March 31 2023 |
| Monetary Funds |
869,549,069.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
629,463,252.32 |
| Advances to Suppliers |
26,323,521.98 |
| Other Receivables |
30,600,449.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
744,071,038.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,860,751.15 |
| Total Current Assets |
2,629,098,979.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,671,696.01 |
| Investment Properties |
4,406,729.19 |
| Fixed Assetes |
1,055,481,060.08 |
| Under-construction Projects |
320,113,154.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
259,934,289.40 |
| R&D expenses |
-- |
| Goodwill |
501,174,066.33 |
| Long-Term Deferred and Prepaid Expenses |
33,106,178.85 |
| Deferred Income Tax Assets |
111,197,389.41 |
| Other Non-Current Assets |
416,379,172.20 |
| Sub-Total of Non-Current Assets |
2,760,615,248.85 |
| Total Assets |
5,389,714,228.08 |
| Short-Term Loans |
379,100,000.00 |
| Trading Financial liabilities |
416,088.22 |
| Notes Payable |
500,384,897.89 |
| Accounts Payable |
614,290,812.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,143,407.64 |
| Taxes Payable |
9,503,232.93 |
| Interest Payable |
-- |
| Dividend Payable |
363,500.00 |
| Other payables |
39,019,711.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
67,663,703.75 |
| Other Current Liabilities |
1,778,434.66 |
| Sub-Total of Current Liabilities |
1,660,197,259.68 |
| Long-term Loans |
261,541,483.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,746,368.45 |
| Other Non-Current Liabilities |
239,980,000.00 |
| Sub-Total of Non-Current Liabilities |
822,055,870.48 |
| Total Liabilities |
2,482,253,130.16 |
| Paid-In Capital(Or Share Stock) |
657,183,090.00 |
| Capital Surplus |
1,594,078,880.04 |
| Surplus Reserve |
59,253,385.59 |
| LESS:Treasury Stock |
26,866,700.00 |
| Undistributed Profits |
546,838,586.34 |
| Minority Stockholder's Interest |
76,973,855.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,830,487,241.97 |
| Owner's Equity（Stockholder's Equity） |
2,907,461,097.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,389,714,228.08 |
